22
Participants
Start Date
September 14, 2021
Primary Completion Date
November 15, 2022
Study Completion Date
November 15, 2022
Dexmedetomidine
Patients will undergo the usual anal manometry study, with no adjuvant medications, per routine practice currently in the gastrointestinal unit. Following completion of manometry, 0.5 mcg/kg DEX will be administered over 1 minute followed by an infusion of 0.15 mcg/kg/hr. Manometry measurements will be followed for 15 minutes in response to DEX.
Boston Children's Hospital, Boston
Boston Children's Hospital
OTHER